Mono Pharmacare Limited Financial Ratios
MONOPHARMA · Healthcare · Current price ₹8.9
P/E ratio
44.5x
P/B ratio
0.5x
ROE
1.1%
ROCE
4.4%
Debt / Equity
1.79
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 44.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 1.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 4.4% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.79 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Mono Pharmacare Limited's latest numbers.
Mono Pharmacare Limited profitability
Mono Pharmacare Limited generates a return on equity of 1.1% and a return on capital employed of 4.4%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.79 and a P/E of 44.5x, Mono Pharmacare Limited is carrying meaningful debt. Our overall business-quality score for the company is 2.7 / 10.
Understand the ratios
More on Mono Pharmacare Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.